Advertisement

Top Myths of Diagnosis and Management of Infectious Diseases in Hospital Medicine

      Abstract

      Antimicrobial agents are among the most frequently prescribed medications during hospitalization. However, approximately 30% to 50% or more of inpatient antimicrobial use is unnecessary or suboptimal. Herein, we describe 10 common myths of diagnosis and management that often occur in the hospital setting. Further, we discuss supporting data to dispel each of these myths. This analysis will provide hospitalists and other clinicians with a foundation for rational decision-making about antimicrobial use and support antimicrobial stewardship efforts at both the patient and institutional levels.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Magill SS
        • O'Leary E
        • Ray SM
        • et al.
        Assessment of the appropriateness of antimicrobial use in US hospitals.
        JAMA Netw Open. 2021; 4e212007
        • Fridkin S
        • Baggs J
        • Fagan R
        • et al.
        Vital signs: improving antibiotic use among hospitalized patients.
        MMWR Morb Mortal Wkly Rep. 2014; 63: 194-200
        • Vaughn VM
        • Gandhi TN
        • Chopra V
        • et al.
        Antibiotic overuse after hospital discharge: a multi-hospital cohort study.
        Clin Infect Dis. 2021; 73: e4499-e4506
        • Scarpato SJ
        • Timko DR
        • Cluzet VC
        • et al.
        An evaluation of antibiotic prescribing practices upon hospital discharge.
        Infect Control Hosp Epidemiol. 2017; 38: 353-355
        • Conner M
        • Harris WH
        • Bomkamp JP
        ADD It Up: an evaluation of antibiotic duration at hospital discharge at a community hospital.
        Open Forum Infect Dis. 2021; 8: ofab399
        • Klein EY
        • Martinez EM
        • May L
        • Saheed M
        • Reyna V
        • Broniatowski DA
        Categorical risk perception drives variability in antibiotic prescribing in the emergency department: a mixed methods observational study.
        J Gen Intern Med. 2017; 32: 1083-1089
        • Shehab N
        • Lovegrove MC
        • Geller AI
        • KO Rose
        • Weidle NJ
        • Budnitz DS
        Us emergency department visits for outpatient adverse drug events, 2013-2014.
        JAMA. 2016; 316: 2115-2125
        • Tamma PD
        • Avdic E
        • Li DX
        • Dzintars K
        • Cosgrove SE
        Association of adverse events with antibiotic use in hospitalized patients.
        JAMA Intern Med. 2017; 177: 1308-1315
        • Chalmers JD
        • Akram AR
        • Singanayagam A
        • Wilcox MH
        • Hill AT
        Risk factors for Clostridium difficile infection in hospitalized patients with community-acquired pneumonia.
        J Infect. 2016; 73: 45-53
        • Malik U
        • Armstrong D
        • Ashworth M
        • et al.
        Association between prior antibiotic therapy and subsequent risk of community-acquired infections: a systematic review.
        J Antimicrob Chemother. 2018; 73: 287-296
        • Kalil AC
        • Metersky ML
        • Klompas M
        • et al.
        Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society.
        Clin Infect Dis. 2016; 63: e61-e111
        • Augustine MR
        • Testerman TL
        • Justo JA
        • et al.
        Clinical risk score for prediction of extended-spectrum β-lactamase-producing Enterobacteriaceae in bloodstream isolates.
        Infect Control Hosp Epidemiol. 2017; 38: 266-272
        • Baggs J
        • Jernigan JA
        • Halpin AL
        • Epstein L
        • Hatfield KM
        • McDonald LC
        Risk of subsequent sepsis within 90 days after a hospital stay by type of antibiotic exposure.
        Clin Infect Dis. 2018; 66: 1004-1012
        • Rice LB
        The Maxwell Finland Lecture: for the duration-rational antibiotic administration in an era of antimicrobial resistance and Clostridium difficile.
        Clin Infect Dis. 2008; 46: 491-496
        • Chastre J
        • Wolff M
        • Fagon J-Y
        • et al.
        Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.
        JAMA. 2003; 290: 2588-2598
        • Singh N
        • Rogers P
        • Atwood CW
        • Wagener MM
        • Yu VL
        Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription.
        Am J Respir Crit Care Med. 2000; 162: 505-511
        • Spellberg B
        The new antibiotic mantra-“Shorter Is Better.
        JAMA Intern Med. 2016; 176: 1254-1255
        • SJ Johnson
        • Ernst EJ
        • Moores KG
        Is double coverage of gram-negative organisms necessary?.
        Am J Health Syst Pharm. 2011; 68: 119-124
        • Schultz L
        • Lowe TJ
        • Srinivasan A
        • Neilson D
        • Pugliese G
        Economic impact of redundant antimicrobial therapy in US hospitals.
        Infect Control Hosp Epidemiol. 2014; 35: 1229-1235
        • Huttner B
        • Jones M
        • Rubin MA
        • et al.
        Double trouble: how big a problem is redundant anaerobic antibiotic coverage in Veterans Affairs medical centres?.
        J Antimicrob Chemother. 2012; 67: 1537-1539
        • Tunkel AR
        • Hasbun R
        • Bhimraj A
        • et al.
        2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis.
        Clin Infect Dis. 2017; 64: e34-e65
        • Baddour LM
        • Wilson WR
        • Bayer AS
        • et al.
        infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association.
        Circulation. 2015; 132: 1435-1486
        • Evans L
        • Rhodes A
        • Alhazzani W
        • et al.
        Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021.
        Crit Care Med. 2021; 49: e1063-e1143
      1. National Comprehensive Cancer Network. Prevention and treatment of cancer-related infections. 2021. Available at: https://www.nccn.org/guidelines/guidelines-detail?category=3&id=1457. Accessed January 4, 2022.

        • Tamma PD
        • Cosgrove SE
        • Maragakis LL
        Combination therapy for treatment of infections with gram-negative bacteria.
        Clin Microbiol Rev. 2012; 25: 450-470
        • Tong SYC
        • Lye DC
        • Yahav D
        • et al.
        Effect of vancomycin or daptomycin with vs without an antistaphylococcal β-lactam on mortality, bacteremia, relapse, or treatment failure in patients with MRSA bacteremia: a randomized clinical trial.
        JAMA. 2020; 323: 527-537
        • Gandhi TN
        • Malani PN
        Combination therapy for methicillin-resistant Staphylococcus aureus bacteremia: not ready for prime time.
        JAMA. 2020; 323: 515-516
        • Cyriac JM
        • James E
        Switch over from intravenous to oral therapy: a concise overview.
        J Pharmacol Pharmacother. 2014; 5: 83-87
        • Mertz D
        • Koller M
        • Haller P
        • et al.
        Outcomes of early switching from intravenous to oral antibiotics on medical wards.
        J Antimicrob Chemother. 2009; 64: 188-199
        • Li H-K
        • Rombach I
        • Zambellas R
        • et al.
        Oral versus intravenous antibiotics for bone and joint infection.
        N Engl J Med. 2019; 380: 425-436
        • Spellberg B
        • Chambers HF
        • Musher DM
        • Walsh TL
        • Bayer AS
        Evaluation of a paradigm shift from intravenous antibiotics to oral step-down therapy for the treatment of infective endocarditis: a narrative review.
        JAMA Intern Med. 2020; 180: 769-777
        • Sutton JD
        • Stevens VW
        • Chang N-CN
        • Khader K
        • Timbrook TT
        • Spivak ES
        Oral β-lactam antibiotics vs fluoroquinolones or trimethoprim-sulfamethoxazole for definitive treatment of Enterobacterales bacteremia from a urine source.
        JAMA Netw Open. 2020; 3e2020166
        • Coehlo A
        • Robineau O
        • Titecat M
        • et al.
        Fully oral targeted antibiotic therapy for Gram-positive cocci-related periprosthetic joint infections: a real-life before and after study.
        J Antimicrob Chemother. 2021; 76: 3033-3036
        • Arensman K
        • Shields M
        • Beganovic M
        • et al.
        Fluoroquinolone versus beta-lactam oral step-down therapy for uncomplicated streptococcal bloodstream infections.
        Antimicrob Agents Chemother. 2020; 64: e01515-e01520
        • Nicolle LE
        • Gupta K
        • Bradley SF
        • et al.
        Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America.
        Clin Infect Dis. 2019; 68: e83-e110
        • Trautner BW
        • Grigoryan L
        Approach to a positive urine culture in a patient without urinary symptoms.
        Infect Dis Clin North Am. 2014; 28: 15-31
        • Smaill FM
        • Vazquez JC
        Antibiotics for asymptomatic bacteriuria in pregnancy.
        Cochrane Database Syst Rev. 2015; CD000490
        • Advani SD
        • Polage CR
        • Fakih MG
        Deconstructing the urinalysis: a novel approach to diagnostic and antimicrobial stewardship.
        Antimicrob Steward Healthc Epidemiol. 2021; 1: e6
        • Cortes-Penfield NW
        • Trautner BW
        • Jump RLP
        Urinary tract infection and asymptomatic bacteriuria in older adults.
        Infect Dis Clin North Am. 2017; 31: 673-688
        • Foley A
        • French L
        Urine clarity inaccurate to rule out urinary tract infection in women.
        J Am Board Fam Med. 2011; 24: 474-475
        • Schulz L
        • Hoffman RJ
        • Pothof J
        • Fox B
        Top ten myths regarding the diagnosis and treatment of urinary tract infections.
        J Emerg Med. 2016; 51: 25-30
        • Langford BJ
        • Daneman N
        • Diong C
        • et al.
        Antibiotic susceptibility reporting and association with antibiotic prescribing: a cohort study.
        Clin Microbiol Infect. 2021; 27: 568-575
        • Baxter M
        • Bethune C
        • Powell R
        • Morgan M
        Point prevalence of penicillin allergy in hospital inpatients.
        J Hosp Infect. 2020; 106: 65-70
        • Rimawi RH
        • Cook PP
        • Gooch M
        • et al.
        The impact of penicillin skin testing on clinical practice and antimicrobial stewardship.
        J Hosp Med. 2013; 8: 341-345
        • Macy E
        • Contreras R
        Health care use and serious infection prevalence associated with penicillin “allergy” in hospitalized patients: A cohort study.
        J Allergy Clin Immunol. 2014; 133: 790-796
        • Blumenthal KG
        • Peter JG
        • Trubiano JA
        • Phillips EJ
        Antibiotic allergy.
        Lancet. 2019; 393: 183-198
        • Macy E
        • Burchette RJ
        Oral antibiotic adverse reactions after penicillin skin testing: multi-year follow-up.
        Allergy. 2002; 57: 1151-1158
        • Sacco KA
        • Bates A
        • Brigham TJ
        • Imam JS
        • Burton MC
        Clinical outcomes following inpatient penicillin allergy testing: A systematic review and meta-analysis.
        Allergy. 2017; 72: 1288-1296
        • Cooper L
        • Harbour J
        • Sneddon J
        • Seaton RA
        Safety and efficacy of de-labelling penicillin allergy in adults using direct oral challenge: a systematic review.
        JAC Antimicrob Resist. 2021; 3: dlaa123
        • Turner NA
        • Wrenn R
        • Sarubbi C
        • et al.
        Evaluation of a Pharmacist-Led Penicillin Allergy Assessment Program and Allergy Delabeling in a Tertiary Care Hospital.
        JAMA Netw Open. 2021; 4e219820
        • Jeimy S
        • Ben-Shoshan M
        • Abrams EM
        • Ellis AK
        • Connors L
        • Wong T
        Practical guide for evaluation and management of beta-lactam allergy: position statement from the Canadian Society of Allergy and Clinical Immunology.
        Allergy Asthma Clin Immunol. 2020; 16: 95
        • Berríos-Torres SI
        • Umscheid CA
        • Bratzler DW
        • et al.
        Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017.
        JAMA Surg. 2017; 152: 784-791
        • McDonald M
        • Grabsch E
        • Marshall C
        • Forbes A
        Single- versus multiple-dose antimicrobial prophylaxis for major surgery: a systematic review.
        Aust N Z J Surg. 1998; 68: 388-396
        • Branch-Elliman W
        • O'Brien W
        • Strymish J
        • Itani K
        • Wyatt C
        • Gupta K
        Association of duration and type of surgical prophylaxis with antimicrobial-associated adverse events.
        JAMA Surg. 2019; 154: 590-598
        • Bratzler DW
        • Dellinger EP
        • Olsen KM
        • et al.
        Clinical practice guidelines for antimicrobial prophylaxis in surgery.
        Surg Infect. 2013; 14: 73-156
        • Harbarth S
        • Samore MH
        • Lichtenberg D
        • Carmeli Y
        Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance.
        Circulation. 2000; 101: 2916-2921
        • Parry GW
        • Holden SR
        • Shabbo FP
        Antibiotic prophylaxis for cardiac surgery: current United Kingdom practice.
        Br Heart J. 1993; 70: 585-586
        • Phillips BT
        • Wang ED
        • Mirrer J
        • et al.
        Current practice among plastic surgeons of antibiotic prophylaxis and closed-suction drains in breast reconstruction: experience, evidence, and implications for postoperative care.
        Ann Plast Surg. 2011; 66: 460-465
        • Edwards FH
        • Engelman RM
        • Houck P
        • Shahian DM
        • Bridges CR
        • Society of Thoracic Surgeons
        The Society of Thoracic Surgeons Practice Guideline Series: Antibiotic Prophylaxis in Cardiac Surgery, Part I: Duration.
        Ann Thorac Surg. 2006; 81: 397-404
        • Hai Y
        • Chong W
        • Lazar MA
        Extended prophylactic antibiotics for mastectomy with immediate breast reconstruction: a meta-analysis.
        Plast Reconstr Surg Glob Open. 2020; 8: e2613
        • Fried HI
        • Nathan BR
        • Rowe AS
        • et al.
        The insertion and management of external ventricular drains: an evidence-based consensus statement: a statement for healthcare professionals from the Neurocritical Care Society.
        Neurocrit Care. 2016; 24: 61-81
        • Oplinger M
        • Andrews CO
        Nitrofurantoin contraindication in patients with a creatinine clearance below 60 mL/min: looking for the evidence.
        Ann Pharmacother. 2013; 47: 106-111
        • Welch E
        • Sheth S
        • Ashong CN
        • Pham C
        Retrospective review on the safety and efficacy of nitrofurantoin for the treatment of cystitis in the veteran population with or without renal insufficiency.
        Open Forum Infect Dis. 2021; 8: ofab442
        • Cunha BA
        • Cunha CB
        • Lam B
        • et al.
        Nitrofurantoin safety and effectiveness in treating acute uncomplicated cystitis (AUC) in hospitalized adults with renal insufficiency: antibiotic stewardship implications.
        Eur J Clin Microbiol Infect Dis. 2017; 36: 1213-1216
        • Bains A
        • Buna D
        • Hoag NA
        A retrospective review assessing the efficacy and safety of nitrofurantoin in renal impairment.
        Can Pharm J. 2009; 142: 248-252
        • Santos JM
        • Batech M
        • Pelter MA
        • Deamer RL
        Evaluation of the risk of nitrofurantoin lung injury and its efficacy in diminished kidney function in older adults in a large integrated healthcare system: a matched cohort study.
        J Am Geriatr Soc. 2016; 64: 798-805
        • Ingalsbe ML
        • Wojciechowski AL
        • Smith KA
        • Mergenhagen KA
        Effectiveness and safety of nitrofurantoin in outpatient male veterans.
        Ther Adv Urol. 2015; 7: 186-193
        • Ten Doesschate T
        • van Haren E
        • Wijma RA
        • Koch BCP
        • Bonten MJM
        • van Werkhoven CH
        The effectiveness of nitrofurantoin, fosfomycin and trimethoprim for the treatment of cystitis in relation to renal function.
        Clin Microbiol Infect. 2020; 26: 1355-1360
        • American Geriatrics Society 2015 Beers Criteria Update Expert Panel
        American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults.
        J Am Geriatr Soc. 2015; 63: 2227-2246
      2. U.S. Food & Drug Administration (FDA). FDA reinforces safety information about serious low blood sugar levels and mental health side effects with fluoroquinolone antibiotics; requires label changes. Available at:https://www.fda.gov/drugs/drug-safety-and-availability/fda-reinforces-safety-information-about-serious-low-blood-sugar-levels-and-mental-health-side. Accessed November 29, 2021.

      3. U.S. Food & Drug Administration (FDA). FDA Drug Safety Communication: FDA requires label changes to warn of risk for possibly permanent nerve damage from antibacterial fluoroquinolone drugs taken by mouth or by injection. Available at:http://wayback.archive-it.org/7993/20170112031629/http://www.fda.gov/Drugs/DrugSafety/ucm365050.htm. Accessed November 29, 2021.

      4. U.S. Food & Drug Administration (FDA). FDA Drug Safety Communication: FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections; warns about disabling side effects that can occur together. Available at:https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-advises-restricting-fluoroquinolone-antibiotic-use-certain. Accessed November 29, 2021.

      5. U.S. Food & Drug Administration (FDA). FDA Drug Safety Communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects. Available at:https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-updates-warnings-oral-and-injectable-fluoroquinolone-antibiotics. Accessed November 29, 2021.

      6. U.S. Food & Drug Administration (FDA). FDA Drug Safety Communication: FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients. Available at:https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-increased-risk-ruptures-or-tears-aorta-blood-vessel-fluoroquinolone-antibiotics. Accessed November 29, 2021.